ARCHIVES

NCI Director Says Research Budget Cuts Result in Untold “Missed Opportunities,” Provides List of Program Reductions.

This article is from The Cancer Letter archive.

Vol. 33 No. 09 | March 9, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb

July 14, 1995

NCI Advisors Approve Plan For Repository For Prostate Cancer Issue Specimens

March 19, 1999

NCI Director To Decide Fate Of P-4 After NCAB Meeting In June.

April 20, 2007

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001

Study Tests PARP Inhibitor ABT-888 For Several Cancers

September 25, 2009

National Cancer Policy Forum Studies Modernization, Funding Of Cooperative Group Program.

July 11, 2008